Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Amortizatization of Intangibles (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Amortizatization of Intangibles for 10 consecutive years, with $31059.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 228.95% to $31059.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $113546.0, a 89.32% increase, with the full-year FY2024 number at $110452.0, up 16.78% from a year prior.
  • Amortizatization of Intangibles was $31059.0 for Q3 2025 at Creative Medical Technology Holdings, up from $30577.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.4 million in Q4 2021 to a low of -$24087.0 in Q3 2024.
  • A 5-year average of $168820.9 and a median of $23021.0 in 2021 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: soared 1278.68% in 2021, then plummeted 204.63% in 2024.
  • Creative Medical Technology Holdings' Amortizatization of Intangibles stood at $2.4 million in 2021, then crashed by 99.04% to $23021.0 in 2022, then rose by 10.86% to $25521.0 in 2023, then skyrocketed by 197.78% to $75997.0 in 2024, then tumbled by 59.13% to $31059.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Amortizatization of Intangibles are $31059.0 (Q3 2025), $30577.0 (Q1 2025), and $75997.0 (Q4 2024).